Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 10.25% is 78% above its 5-year average of 5.75%, near the high end of its 5-year range (-21.30%–13.65%).
6.16% below its 12-month average of 10.92%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 11.79%.
OPERATING MARGIN
10.25%
OPERATING MARGIN AVG TTM
10.92%
OPERATING MARGIN AVG 3Y
9.91%
OPERATING MARGIN AVG 5Y
5.75%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.16%
CURRENT VS 3Y AVG
+3.41%
CURRENT VS 5Y AVG
+78.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
GoodRx Holdings, Inc.
Market Cap
$1.13B
Operating Margin
10.25%
TTM Avg
10.92%
3Y Avg
9.91%
5Y Avg
5.75%
Market Cap
$1.13B
Operating Margin
14.18%
TTM Avg
9.30%
3Y Avg
5.28%
5Y Avg
4.02%
Market Cap
$1.14B
Operating Margin
-240.38%
TTM Avg
-171.82%
3Y Avg
-189.28%
5Y Avg
-240.55%
Market Cap
$1.13B
Operating Margin
15.66%
TTM Avg
23.78%
3Y Avg
24.92%
5Y Avg
19.79%
Market Cap
$1.13B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Operating Margin
-36.08%
TTM Avg
-28.70%
3Y Avg
-24.53%
5Y Avg
-15.51%
Market Cap
$1.10B
Operating Margin
-4.13%
TTM Avg
-9.12%
3Y Avg
-15.26%
5Y Avg
-9.90%
Market Cap
$1.17B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | $1.13B | 10.25% | 10.92% | 9.91% | 5.75% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 14.18% | 9.30% | 5.28% | 4.02% |
| Nektar Therapeutics (NKTR)vs › | $1.14B | -240.38% | -171.82% | -189.28% | -240.55% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 15.66% | 23.78% | 24.92% | 19.79% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 0.00% | 0.00% | 0.00% | 0.00% |
| Replimune Group, Inc. (REPL)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| OPKO Health, Inc. (OPK)vs › | $1.10B | -36.08% | -28.70% | -24.53% | -15.51% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.10B | -4.13% | -9.12% | -15.26% | -9.90% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
88.0%
Operating Margin
10.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 11.79% |
| 2026-03-31 | 10.08% |
| 2025-12-31 | 11.65% |
| 2025-09-30 | 7.46% |
| 2025-06-30 | 13.65% |
| 2025-03-31 | 11.52% |
| 2024-12-31 | 9.15% |
| 2024-09-30 | 10.45% |
| 2024-06-30 | 9.91% |
| 2024-03-31 | 3.73% |
| 2023-12-31 | -9.30% |
| 2023-09-30 | -21.30% |
| 2023-06-30 | 9.65% |
| 2023-03-31 | 6.14% |
| 2022-12-31 | 0.94% |
| 2022-09-30 | -8.39% |
| 2022-06-30 | -2.11% |
| 2022-03-31 | 9.72% |
| 2021-12-31 | 5.51% |
| 2021-09-30 | 3.59% |
| 2021-06-30 | -0.20% |
| 2021-03-31 | -3.12% |
| 2020-12-31 | -195.02% |
| 2020-09-30 | -43.92% |
| 2020-06-30 | 33.85% |
| 2020-03-31 | 32.73% |
| 2019-12-31 | 31.58% |
| 2019-09-30 | 37.19% |
| 2019-06-30 | 41.59% |
| 2019-03-31 | 38.70% |
